Precision Fluid Management in Continuous Renal Replacement Therapy

Blood Purification

Volumn 42, Issue 3, 2016, Pages 266-278

  Murugan, Raghavan ^a   Hoste, Eric ^d,e   Mehta, Ravindra L ^c   Samoni, Sara ^f   Ding, Xiaoqiang ^h   Rosner, Mitchell H ^b   Kellum, John A ^a   Ronco, Claudio ^g  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

^f SCUOLA SUPERIORE SANT ANNA   (Italy)

^g SAN BORTOLO HOSPITAL   (Italy)

^h FUDAN UNIVERSITY   (China)

Author keywords

Continuous renal replacement therapy; Fluid; Hemodialysis; Management; Precision medicine

Indexed keywords

ACID BASE BALANCE; ARTICLE; CONTINUOUS ARTERIOVENOUS HEMODIALYSIS AND CONTINUOUS VENOVENOUS HEMODIAFILTRATION; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; DIALYSATE; ELECTROLYTE BALANCE; FLOW RATE; FLUID BALANCE; FLUID THERAPY; HEMODIALYSIS; HUMAN; HYPERNATREMIA; HYPERVOLEMIA; HYPONATREMIA; KIDNEY BLOOD FLOW; LUNG EDEMA; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SLOW CONTINUOUS ULTRAFILTRATION; CRITICAL ILLNESS; DISEASE MANAGEMENT; HOMEOSTASIS; PLASMA; PROCEDURES; RENAL REPLACEMENT THERAPY; TIME FACTOR;

CITRIC ACID; DIALYSIS FLUID;

CITRATES; CRITICAL ILLNESS; DIALYSIS SOLUTIONS; DISEASE MANAGEMENT; FLUID THERAPY; HOMEOSTASIS; HUMANS; PLASMA; PRECISION MEDICINE; RENAL REPLACEMENT THERAPY; TIME FACTORS; WATER-ELECTROLYTE BALANCE;

EID: 84988365225     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000448528     Document Type: Article

References (32)

1. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-887.
2. Rosner MH, Ostermann M, Murugan R, Prowle JR, Ronco C, Kellum JA, et al. Indications and management of mechanical fluid removal in critical illness. Br J Anaesth 2014;113:764-771.
3. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C; ADQI Workgroup: The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002;62:1855-1863.
4. Gibney N, Cerda J, Davenport A, Ramirez J, Singbartl K, Leblanc M, et al. Volume management by renal replacement therapy in acute kidney injury. Int J Artif Organs 2008;31:145-155.
5. Bouchard J, Mehta RL: Volume management in continuous renal replacement therapy. Semin Dial 2009;22:146-150.
6. Bihorac A, Ross EA: Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Am J Kidney Dis 2005;46:908-918.
7. Tolwani A, Wille KM: Advances in continuous renal replacement therapy: citrate anticoagulation update. Blood Purif 2012;34:88-93.
8. Joannidis M, Oudemans-van Straaten HM: Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care 2007;11:218.
9. Macedo E, Mehta RL: Continuous dialysis therapies: core curriculum 2016. Am J Kidney Dis 2016;pii:S0272-6386(16)30097-X.
10. de Pont AC, Bouman CS, Bakhtiari K, Schaap MC, Nieuwland R, Sturk A, et al. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis. ASAIO J 2006;52:416-422.
11. van der Voort PH, Gerritsen RT, Kuiper MA, Egbers PH, Kingma WP, Boerma EC: Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation. Blood Purif 2005;23:175-180.
12. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 2003;94:c94-c98.
13. Davenport A: Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis 2001;37:457-466.
14. Han SS, Bae E, Kim DK, Kim YS, Han JS, Joo KW: Dysnatremia, its correction, and mortality in patients undergoing continuous renal replacement therapy: a prospective observational study. BMC Nephrol 2016;17:2.
15. Kraus MA: Selection of dialysate and replacement fluids and management of electrolyte and acid-base disturbances. Semin Dial 2009;22:137-140.
16. Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E: Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol 2014;9:2173-2188.
17. Zhang L, Chen Z, Diao Y, Yang Y, Fu P: Associations of fluid overload with mortality and kidney recovery in patients with acute kidney injury: a systematic review and meta-analysis. J Crit Care 2015;30:860.e7-e13.
18. Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther 2014;46:361-380.
19. O'Connor ME, Prowle JR: Fluid overload. Crit Care Clin 2015;31:803-821.
20. Davies H, Leslie GD, Morgan D: A retrospective review of fluid balance control in CRRT. Aust Crit Care 2016;pii:S1036-7314(16)30037-30036.
21. Xu J, Ding X, Fang Y, Shen B, Liu Z, Zou J, et al. New, goal-directed approach to renal replacement therapy improves acute kidney injury treatment after cardiac surgery. J Cardiothorac Surg 2014;9:103.
22. Hoste EA, Maitland K, Brudney CS, Mehta R, Vincent JL, Yates D, et al. Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth 2014;113:740-747.
23. Daugirdas JT: Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001;38(4 suppl 4):S11-S17.
24. Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2011;79:250-257.
25. Rabindranath K, Adams J, Macleod AM, et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007;3:CD003773.
26. Schneider AG, Bellomo R, Bagshaw SM, Glassford NJ, Lo S, Jun M, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 2013;39:987-997.
27. Xu J, Shen B, Fang Y, Liu Z, Zou J, Liu L, et al. Postoperative fluid overload is a useful predictor of the short-term outcome of renal replacement therapy for acute kidney injury after cardiac surgery. Medicine (Baltimore) 2015;94:e1360.
28. Claure-Del Granado R, Bouchard J: Acid-base and electrolyte abnormalities during renal support for acute kidney injury: recognition and management. Blood Purif 2012;34:186-193.
29. Dangoisse C, Dickie H, Tovey L, Ostermann M: Correction of hyper- and hyponatraemia during continuous renal replacement therapy. Nephron Clin Pract 2014;128:394-398.
30. Sigler MH: Transport characteristics of the slow therapies: implications for achieving adequacy of dialysis in acute renal failure. Adv Ren Replace Ther 1997;4:68-80.
31. Kalantari K, Chang JN, Ronco C, Rosner MH: Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int 2013;83:1017-1028.
32. Huang Z, Letteri JJ, Ronco C, Gao R, Clark WR: Predilution and postdilution reinfusion techniques; in Ronco C, Bellomo R, Kellum J (eds): Critical Care Nephrology, ed 2. Saunders, 2009, pp 1370-1374.